Afuco™ Anti-Human CLEC4C ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CLEC4C ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an antibody that bind to BDCA2 to induce death of a plasmacytoid dendritic cell, inhibit production or secretion of inflammatory cytokines and chemokines, and treat or prevent immunological disorders such as inflammatory and autoimmune conditions.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-164CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CLEC4C |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |